PeptideDB

MLT-231 2682102-10-7

MLT-231 2682102-10-7

CAS No.: 2682102-10-7

MLT-231 is a specific allosteric MALT1 inhibitor (antagonist) with IC50 of 9 nM. MLT-231 specifically blocks endogenous
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

MLT-231 is a specific allosteric MALT1 inhibitor (antagonist) with IC50 of 9 nM. MLT-231 specifically blocks endogenous BCL10 cleavage with IC50 of 160 nM. MLT-23 has anticancer effect in ABC-DLBCL xenograft models.

Physicochemical Properties


Molecular Formula C19H19CLF3N7O2
Molecular Weight 469.848072290421
Exact Mass 469.124
CAS # 2682102-10-7
PubChem CID 146680905
Appearance White to off-white solid powder
LogP 2.6
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 9
Rotatable Bond Count 3
Heavy Atom Count 32
Complexity 665
Defined Atom Stereocenter Count 2
SMILES

C[C@H]1COC[C@@H](N1C2=C(C=NC3=CC(=NN32)Cl)NC(=O)NC4=CC(=NC=C4)C(F)(F)F)C

InChi Key BFPCFGGFGQMJQG-QWRGUYRKSA-N
InChi Code

InChI=1S/C19H19ClF3N7O2/c1-10-8-32-9-11(2)29(10)17-13(7-25-16-6-15(20)28-30(16)17)27-18(31)26-12-3-4-24-14(5-12)19(21,22)23/h3-7,10-11H,8-9H2,1-2H3,(H2,24,26,27,31)/t10-,11-/m0/s1
Chemical Name

1-[2-chloro-7-[(3S,5S)-3,5-dimethylmorpholin-4-yl]pyrazolo[1,5-a]pyrimidin-6-yl]-3-[2-(trifluoromethyl)pyridin-4-yl]urea
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro MLT-231 (19.5–10,000 nM) prevents OCI-Ly3 cells from proliferating. MLT-231 (50-5000 nM; 24 hours) suppresses the expression of the NF-κB target gene IRF4 while causing the uncleaved forms of its substrates, CYLD, BCL10, and RELB, to accumulate[1].
ln Vivo In the ABC-DLBCL xenograft model, MLT-231 (10-100 mg/kg; po; bid schedule for 2 weeks) exhibits in vivo efficacy[1]. Following IV administration of MLT-231 (1 mg/kg) to BALB/c mice, the CL, t1/2, and Vss are, respectively, 11 mL/min/kg, 1.9 hours, and 1.5 L/kg[1]. Following intravenous administration of MLT-231 (1 mg/kg) to Sprague-Dawley rats, the CL, t1/2, and Vss are 41 mL/min/kg, 3.2 hours, and 9.4 L/kg, respectively[1]. The AUC0-24, Cmax, and F values for MLT-231 (3 mg/kg; po; BALB/c mice) are 3096 nM/h, 549 nM, and 99%, respectively[1]. The AUC0-24, Cmax, and F values for MLT-231 (3 mg/kg; po; Sprague-Dawley rats) are 547 nM/h, 46 nM, and 61%, correspondingly.
Cell Assay Western Blot Analysis[1]
Cell Types: OCI-Ly3 cells
Tested Concentrations: 50-5000 nM
Incubation Duration: 24 hrs (hours)
Experimental Results: NF-κB target gene IRF4 was suppressed.
Animal Protocol Animal/Disease Models: Scid-beige mice (OCI-Ly10 ABC-DLBCL type xenograft model)[1]
Doses: 10, 30, and 100 mg/kg
Route of Administration: Po; bid schedule for 2 weeks
Experimental Results: Led to tumor stasis, while being well tolerated.
References

[1]. Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing [published online ahead of print, 2020 Nov 30]. J Med Chem. 2020;10.1021/acs.jmedchem.0c01245.


Solubility Data


Solubility (In Vitro) DMSO: 110 mg/mL (234.12 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 6 mg/mL (12.77 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 60.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 5.5 mg/mL (11.71 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 55.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.1283 mL 10.6417 mL 21.2834 mL
5 mM 0.4257 mL 2.1283 mL 4.2567 mL
10 mM 0.2128 mL 1.0642 mL 2.1283 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.